Bradley Foster & Sargent Inc Ionis Pharmaceuticals Inc Transaction History

Bradley Foster & Sargent Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$31.71 - $43.0 $540,655 - $733,150	-17,050 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $509,454 - $631,532	17,050 New	17,050 $632,000
Q1 2021 Apr 26, 2021	SELL	$42.51 - $63.78 $895,983 - $1.34 Million	-21,077 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$45.3 - $60.27 $954,788 - $1.27 Million	21,077 New	21,077 $1.19 Million
Q3 2020 Oct 26, 2020	SELL	$47.45 - $62.95 $38,149 - $50,611	-804 Closed	0 $0
Q1 2020 May 07, 2020	SELL	$41.6 - $63.4 $12,272 - $18,703	-295 Reduced 26.84%	804 $38,000
Q4 2019 Jan 29, 2020	BUY	$53.85 - $65.27 $15,885 - $19,254	295 Added 36.69%	1,099 $66,000
Q3 2019 Oct 30, 2019	BUY	$59.06 - $72.15 $47,484 - $58,008	804 New	804 $49,000
Q2 2019 Aug 08, 2019	SELL	$62.09 - $86.14 $1.54 Million - $2.14 Million	-24,877 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$52.92 - $81.17 $1.32 Million - $2.02 Million	24,877 New	24,877 $2.02 Million
Q2 2018 Jul 31, 2018	SELL	$40.53 - $50.7 $272,523 - $340,906	-6,724 Closed	0 $0
Q1 2018 May 07, 2018	BUY	$44.08 - $55.05 $296,393 - $370,156	6,724 New	6,724 $296,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

Stay updated on Bradley Foster & Sargent Inc with notifications on news.